EBITDA for Johnson & Johnson (JNJ)
According to Johnson & Johnson's latest reported financial statements, the company's current EBITDA (TTM) is $29.27B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$29.27B
YoY change
+65.7%
5Y CAGR
+11.4%
Peak year (2025)
$41.05B
Cumulative EBITDA
$582.57B
EBITDA history chart for Johnson & Johnson (JNJ) from 1985 to 2025
EBITDA history table for Johnson & Johnson (JNJ) from 1985 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $41.05B | +65.7% | ||
| 2024 | $24.78B | +6.3% | ||
| 2023 | $23.32B | -12.3% | ||
| 2022 | $26.61B | -0.5% | ||
| 2021 | $26.75B | +11.8% | ||
| 2020 | $23.93B | -2.9% | ||
| 2019 | $24.66B | -4.9% | ||
| 2018 | $25.93B | +6.9% | ||
| 2017 | $24.25B | -0.1% | ||
| 2016 | $24.28B | +3.4% | ||
| 2015 | $23.49B | -6.0% | ||
| 2014 | $24.99B | +24.6% | ||
| 2013 | $20.06B | +11.6% | ||
| 2012 | $17.97B | +11.7% | ||
| 2011 | $16.09B | -20.9% | ||
| 2010 | $20.34B | +7.2% | ||
| 2009 | $18.98B | -6.0% | ||
| 2008 | $20.20B | +23.5% | ||
| 2007 | $16.36B | +3.0% | ||
| 2006 | $15.89B | +6.4% | ||
| 2005 | $14.92B | +3.1% | ||
| 2004 | $14.48B | +13.7% | ||
| 2003 | $12.74B | +12.3% | ||
| 2002 | $11.34B | +19.5% | ||
| 2001 | $9.49B | +15.6% | ||
| 2000 | $8.21B | +9.5% | ||
| 1999 | $7.50B | +18.7% | ||
| 1998 | $6.31B | +11.0% | ||
| 1997 | $5.69B | +7.1% | ||
| 1996 | $5.31B | +21.6% | ||
| 1995 | $4.37B | +23.7% | ||
| 1994 | $3.53B | +17.3% | ||
| 1993 | $3.01B | +6.1% | ||
| 1992 | $2.84B | +6.8% | ||
| 1991 | $2.66B | +7.7% | ||
| 1990 | $2.47B | +18.8% | ||
| 1989 | $2.08B | +15.6% | ||
| 1988 | $1.79B | +14.7% | ||
| 1987 | $1.56B | +24.3% | ||
| 1986 | $1.26B | +15.4% | ||
| 1985 | $1.09B | — |
EBITDA values are taken from Johnson & Johnson's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Johnson & Johnson (JNJ) reported EBITDA of $41.05B – surged 65.7% year-over-year.
Johnson & Johnson EBITDA has grown for 2 consecutive years, with a +11.4% compound annual growth rate over 2020–2025 (5 years).
Across the available history, EBITDA reached its high of $41.05B in 2025 and its low of $1.09B in 1985.
Among 8 Healthcare peers, Johnson & Johnson (JNJ) ranks 2nd; the peer median for EBITDA is $21.44B.
Johnson & Johnson EBITDA by Year
Johnson & Johnson EBITDA 2025: $41.05B
Johnson & Johnson EBITDA in 2025 was $41.05B, surged 65.7% from 2024. This figure represents the highest annual value in the available history.
Johnson & Johnson EBITDA 2024: $24.78B
Johnson & Johnson EBITDA in 2024 was $24.78B, grew 6.3% from 2023.
Johnson & Johnson EBITDA 2023: $23.32B
Johnson & Johnson EBITDA in 2023 was $23.32B, declined 12.3% below 2022.
Johnson & Johnson EBITDA 2022: $26.61B
Johnson & Johnson EBITDA in 2022 was $26.61B, edged down 0.5% below 2021.
Johnson & Johnson EBITDA 2021: $26.75B
Johnson & Johnson EBITDA in 2021 was $26.75B.
See more financial history for Johnson & Johnson (JNJ).
Sector peers — EBITDA
Companies in the same sector as Johnson & Johnson, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $11.47B | Healthcare |
Frequently asked questions
What is Johnson & Johnson's EBITDA?
- Latest reported EBITDA for Johnson & Johnson (JNJ) is $29.27B (period ending March 31, 2026).
How has Johnson & Johnson EBITDA changed year-over-year?
- Johnson & Johnson (JNJ) EBITDA changed +65.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Johnson & Johnson EBITDA?
- Johnson & Johnson (JNJ) EBITDA compound annual growth rate is +11.4% over the most recent 5 years available.
When did Johnson & Johnson EBITDA hit its highest annual value?
- Johnson & Johnson EBITDA reached its highest annual value of $41.05B in 2025.
What was Johnson & Johnson EBITDA in 2024?
- Johnson & Johnson (JNJ) EBITDA in 2024 was $24.78B.
What was Johnson & Johnson EBITDA in 2025?
- Johnson & Johnson (JNJ) EBITDA in 2025 was $41.05B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
JNJ Overview
Company profile, financial tools, and key metrics
JNJ Revenue Counter
Earns $3,066 every second. See per minute, hour, and day.
JNJ Earnings Counter
Earns $657.60 per second net profit. See per minute, hour, and day.
JNJ Economic Scale
Exceeds Costa Rica's GDP. Compare with world economies.
JNJ What If Invested
What if you had invested $1,000? See historical returns from any date.
JNJ How It Makes Money
Discover visual breakdown of $96.68B in revenue — where it comes from and where it goes.
JNJ Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
JNJ Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
JNJ Daily Price Character
Steady · 47.0% historical win rate (green days). Streaks & record days.
JNJ Buybacks
1.00% TTM buyback yield. Shareholder yield & SBC comparison.
JNJ Stock Split History
7 splits on record. Dates, ratios, and cumulative multiple.
JNJ Dividend Profile
Yield: 2.29%. Safety: 6/8. See full history.
JNJ Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
JNJ Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.